Literature DB >> 25316024

Quality improvement: an assessment of participation and attitudes of medical oncologists.

Charles Lim1, Matthew C Cheung1, Bryan Franco1, Laavanya Dharmakulaseelan1, Evan Chong1, Amesha Iyngarathasan1, Simron Singh2.   

Abstract

PURPOSE: Although quality improvement (QI) is an integral part of cancer care, there are few QI publications in the medical oncology literature. We examined the prevailing attitudes of medical oncologists toward QI and causes for the low QI publication rate in the medical oncology literature.
METHODS: Using a modified Dillman method, we distributed a 13-question online survey to medical oncologists across Canada asking about their attitudes toward and involvement in QI and perceived barriers to publishing QI studies.
RESULTS: We attained a 43% response rate (143 of 332). Of the responding oncologists, 97% (138) agreed that QI was an important aspect of their practice, although only 49% (70) had participated in QI in the past 5 years. Physicians with administrative responsibility were more likely than clinicians to be involved in QI (P = .008). Most QI participants focused on domains of safety (70%) and patient centeredness (67%). Among QI participants, 72% did not publish their findings, because of lack of time (34%), no identifiable journals (14%), and unfamiliarity with QI methodology (10%). Barriers for QI nonparticipants included uncertainty about how to get involved (45%), lack of time (18%), and limited institutional support or recognition (18%). QI participants had greater awareness of recent practice-changing QI publications compared with nonparticipants (P = .003).
CONCLUSION: Canadian medical oncologists face limitations to participating in and publishing QI initiatives because of lack of knowledge about ongoing initiatives, lack of time, and lack of resources to aid publication. Improving networking opportunities and prioritizing QI at the institutional level can address this need.
Copyright © 2014 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2014        PMID: 25316024     DOI: 10.1200/JOP.2014.001515

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  3 in total

1.  Rheumatologists' perception of systemic lupus erythematosus quality indicators: significant interest and perceived barriers.

Authors:  Carolyn Casey; Cecilia P Chung; Leslie J Crofford; April Barnado
Journal:  Clin Rheumatol       Date:  2016-11-22       Impact factor: 2.980

2.  Quality assessments for cancer centers in the European Union.

Authors:  Anke Wind; Abinaya Rajan; Wim H van Harten
Journal:  BMC Health Serv Res       Date:  2016-09-07       Impact factor: 2.655

3.  The need for dedicated time for medical physicists practice quality improvement efforts in radiation oncology department: A commentary.

Authors:  Richard Zellars; Christopher Njeh; Scott Marquette
Journal:  J Appl Clin Med Phys       Date:  2022-01-18       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.